Congress clarifies: federal grants can now buy fentanyl test strips
S. 5732 — Preventing Overdoses with Test Strips Act · Filed by Cory Booker (D-NJ) · Introduced Nov 17, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends two federal public health laws to explicitly allow grant money to be spent on fentanyl and xylazine test strips and similar detection devices. Currently, grants under these programs may not clearly cover such supplies; the bill removes that ambiguity so public health agencies, harm-reduction programs, and substance-abuse treatment providers can use federal funds to purchase and distribute test strips that help people detect dangerous adulterants in drugs before use.
Why we flagged it
The bill's sole operative mechanism is to clarify that federal substance-abuse and public-health grants may fund overdose-detection devices. It is a straightforward public-health measure addressing a known gap in grant-program language.
What the text implies
- Clarifying language may prompt retrospective review of prior grant spending; agencies may seek guidance on whether past test-strip purchases were compliant or require remediation.
- The definition of 'adulterant substance detection device' is cross-referenced to the 21st Century Cures Act and may evolve if that statute is amended, creating potential future scope creep or contraction.
- Grant recipients in states with legal barriers to harm-reduction supplies (e.g., paraphernalia laws) may face state-law conflicts even with federal authorization, limiting practical effect in some jurisdictions.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill removes a regulatory barrier that prevented federal grant money from being used for overdose-prevention tools. People struggling with substance use and harm-reduction programs gain clearer access to fentanyl and xylazine detection devices, which are evidence-based tools for reducing overdose deaths. No offsetting cost to citizens is apparent.
Who stands to gain
- test strip manufacturers and distributors
- harm-reduction organizations receiving federal grants
- substance-abuse treatment providers receiving federal grants
Named in the bill
21st Century Cures Act, Public Health Service Act, Substance Abuse and Mental Health Services Administration (SAMHSA), fentanyl, xylazine
Where it stands
- Nov 17, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Nov 17, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,801 characters) on Nov 21, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-11-22.
“Congress clarifies: federal grants can now buy fentanyl test strips” QuorumCivic. https://share.quorumcivic.app/bill/119/s5732 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.